A number of researchers have found that maternal pregestational comorbidities (chronic hypertension, cardiovascular disease, rheumatoid arthritis, chronic kidney disease, diabetes, COVID-19, HIV infection, thyroid hormones, cigarette smoking, and cancer) may enhance the likelihood of having a high sFlt1/PlGF ratio. This evidence concerns the gene PGF and cardiovascular disorder.